HOXB13 and posterior cortical atrophy: In summary, these data demonstrate that CCS1477 can effectively suppress HOXB13-loss-induced PCa metastasis in vivo without apparent toxicity, and thus may represent a promising therapeutic strategy for metastatic PCa with low HOXB13 expression.